The growth of this market is majorly driven by the rising demand for sterilized pharmaceutical formulations, increasing demand for medical devices. The technological advancements in cleanroom technology along with the increasing demand for cleanroom technologies in developing economies are expected to offer significant opportunities for market growth in the coming years.
The technical limitations associated with their operational costs and technical challenges associated with the customization of cleanroom designs in developing economies are hindering the growth of this market to a certain extent.
Currently, there are hundreds of monoclonal antibodies, vaccines, and biologics in clinical development. The faster approval of new drugs drives the demand for cleanrooms for their manufacturing. Also, since many of the biologics are pathogenic, it is essential to maintain aseptic conditions during their manufacturing. Thus, cleanrooms form an essential component in the manufacturing of biologics.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263122482
Cleanrooms are mostly designed according to customer requirements based on product specifications and customer-specific design requirements. However, there are no specific guidelines for cleanroom designs for different application areas or product types. This leads to several challenges for cleanroom manufacturers, as they need to follow different designs every time.
Furthermore, regulations do not provide requirements regarding the environmental, product, or facility parameters that are to be controlled. Instead, they only provide standards that a company needs to meet after it decides to manufacture a product using a cleanroom environment.
The high and growing number of pharmaceutical, biotech, and medical device companies facilitating the use of disposable protective clothing has resulted in the increased adoption of the consumables in the market. Also, the large number of R&D activities in the healthcare industry is resulting in a stable demand for cleanroom consumables among end users.
The pharmaceutical industry end-user segment accounted for the largest share of the market in 2019. This is attributed to the industrial growth in this sector, the robust pipeline of injectable formulations, and rising focus on ensuring the quality of healthcare products.
The market in the North America accounted for the largest share in 2020. Factors such as stringent regulatory standards for product approvals; technological advancements in cleanrooms; large number of hospitals in the region; greater adoption of technologically advanced solutions by pharmaceutical, biotechnology, and medical device manufacturing companies; and growth of the healthcare sector are expected to contribute to the growth of the market in North America in the coming years.
The prominent players in the cleanroom technology market include Azbil Corporation (Japan), Kimberly-Clark Corporation (US), Ardmac (Ireland), Clean Air Products (US), Labconco Corporation (US), Dynarex Corporation (US), DuPont de Nemours, Inc. (US), Illinois Tool Works, Inc. (US), Taikisha Ltd. (Japan), Exyte AG (Germany), COLANDIS GmbH (Germany), ABN Cleanroom Technology (Belgium), Clean Rooms International, Inc. (US), Bouygues Group (France), Terra Universal, Inc. (US), Connect 2 Cleanrooms Ltd. (UK), Camfil (Sweden), OCTANORM-Vertriebs-GmbH (Germany), Parteco srl (Italy), Airtech Japan, Ltd. (Japan), Berkshire Corporation (US), AIRPLAN (Spain), Clean Air Technology, Inc. (US), Weiss Technik (Germany), and Atlas Environments (UK).